Many women report vasomotor symptoms, including hot flushes and night sweats, during the menopausal transition. While estrogen is clearly one of the most effective treatments for vasomotor symptoms, recent concerns regarding the use of hormone replacement therapy (HRT) have made treaters much more reluctant to recommend HRT, even for short-term management of vasomotor symptoms. [...]
Monthly Archives: March 2008


Untreated Maternal Depression: What is the Impact on the Unborn Child?
Posted on March 27, 2008
Depression during pregnancy is common. While concerns have been raised regarding the potential teratogenic and long-term neurobehavioral effects of psychotropic drug use during pregnancy, what is often overlooked is the fact that untreated maternal depression may also put the unborn baby at risk.
Maternal depressive symptoms during pregnancy have been shown to be associated with a [...]

Top Ten Blog Posts on the Women’s Mental Health Blog
Posted on March 21, 2008
Since the launch of our blog we’ve addressed many issues and questions in the field of Women’s Mental Health. Compiled below is a list of our most popular blog posts, on topics ranging from the safety of psychotropic drug use during pregnancy to postpartum depression.
1. Can Women Suffer from Postpartum Depression after Miscarriage? - Oct. [...]

Hormone Replacement Therapy Revisited
Posted on March 13, 2008
As a result of dramatically increased life expectancies in industrialized countries, healthy women today expect to spend nearly 40% of their lives after menopause. For these postmenopausal women, lack of estrogen may contribute to long-term adverse effects, including cardiovascular disease and osteoporosis. Many postmenopausal women might benefit from hormone replacement therapy (HRT) with estrogens [...]

Desvenlafaxine for the Treatment of Menopausal Hot Flushes
Posted on March 7, 2008
Last Friday, Wyeth received FDA approval for the antidepressant desvenlafaxine succinate (marketed under the name Pristiq), a metabolite of venlafaxine or Effexor. Although this drug was approved for the treatment of major depression, a recent study has demonstrated that desvenlafaxine could be an effective treatment for vasomotor symptoms in postmenopausal women.
Many women report vasomotor [...]

Depression is More Common in Women with High Risk Pregnancies
Posted on March 6, 2008
Epidemiologic studies suggest that about 10% to 15% of women suffer from clinically significant depressive symptoms during pregnancy. Little is known, however, about the prevalence of depression among women with high risk pregnancies. A recent study published online in the Journal of Clinical Psychiatry suggests that this population may be at significant risk for [...]

Vote for The Center for Women’s Mental Health in the Blogger’s Choice Awards
Posted on March 3, 2008
Our blog has been nominated for Best Health Blog for the 2008 Blogger’s Choice Awards. We are very excited about this nomination and hope that being voted one of the top blogs in the health field will introduce more people to the important issues in perinatal and reproductive psychiatry.
Please take a few minutes and [...]


